FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2472541503> ?p ?o ?g. }

• W2472541503 abstract "Abstract Introduction Multiple myeloma (MM)-bone disease occurs in 70% to 80% of patients at MM diagnosis, and up to 90% at relapse; skeletal related events cause high morbidity and mortality. MM-bone disease is mostly consisting of lytic lesions arising as a consequence of an unbalanced bone remodelling due to activation of osteoclasts (OCs), and inactivation of osteoblasts. Osteoclastogenesis may be under immunoregulation by T-cells through the production of receptor activator of NF-kB ligand (RANKL), that is the OC differentiating molecule. Aim By means of an in vitro osteoclastogenesis model derived from peripheral blood mononuclear cells (PBMCs) of patients with MM-lytic bone disease, we purposed to evaluate OC formation and T-cell RANKL expression at diagnosis, and in the setting of frontline therapy. Methods PB was taken by venipuncture from 18 patients (7 men and 11 women), aged from 63 to 84, diagnosed as having symptomatic MM by International Myeloma Working Group (IMWG) criteria. In all of them, lytic lesions were demonstrated by skeleton standard radiography, and in some cases by nuclear magnetic resonance (NMR) too. On the basis of patients’ age and fitness, initial standard therapy consisting of proteasome inhibitor (Bortezomib) associated with Melphalan and Prednisone (VMP) was administered for nine cycles. The therapy response was assessed according to IMWG criteria. The controls included PB collected from 20 healthy donors, matched for age and sex with the patients. Controls and patients gave their written informed consent to the study, that was approved by the local Ethical Committee and performed according to the Declaration of Helsinki. PB was taken from the patients at diagnosis, and following the fourth and the ninth VMP cycles, respectively. OCs were obtained from unfractionated PBMC cultures either stimulated or not with the exogenous pro-osteoclastogenic cytokines [macrophage-colony stimulating factor (M-CSF) and RANKL]. Mature OCs were identified as multinucleated tartrate-resistant acid phosphatase (TRAP) positive cells. Freshly isolated T-cells from patients’ and controls’ PBMCs were lysed and analyzed by Western Blotting to evaluate RANKL expression. Results Spontaneous osteoclastogenesis was demonstrated in the cultures derived from PBMCs isolated at diagnosis. With particular regard to the patients achieving a deep treatment response, at the end of the culture period we found that PBMCs formed few small-sized OCs, when cultured in the absence of M-CSF and RANKL. Moreover, fresh T-cells purified after four and nine VMP cycles expressed progressively lower RANKL levels than fresh T-cells purified at diagnosis. Otherwise the cultures derived from non-responsive patients’ PBMCs, collected during and after treatment respectively, showed in vitro spontaneous formation of numerous and large OCs, overlapping the results at diagnosis. Fresh T-cells purified during or after treatment expressed comparable or even higher RANKL levels respect to diagnosis. Conclusions These findings show that in vitro spontaneous osteoclastogenesis and T-cell RANKL expression may be correlated with the response to treatment in patients with MM-lytic bone disease. However, further studies will be necessary to confirm these data, and to better translate them from a biologic to a clinical point of view. Disclosures: No relevant conflicts of interest to declare." @default.
• W2472541503 created "2016-07-22" @default.
• W2472541503 creator A5000873286 @default.
• W2472541503 creator A5003063004 @default.
• W2472541503 creator A5004697477 @default.
• W2472541503 creator A5005276198 @default.
• W2472541503 creator A5009981948 @default.
• W2472541503 creator A5016695149 @default.
• W2472541503 creator A5033896229 @default.
• W2472541503 creator A5046114745 @default.
• W2472541503 creator A5057593886 @default.
• W2472541503 creator A5064478569 @default.
• W2472541503 creator A5072483254 @default.
• W2472541503 creator A5083991779 @default.
• W2472541503 date "2013-11-15" @default.
• W2472541503 modified "2023-09-27" @default.
• W2472541503 title "In Vitro Osteoclastogenesis and T-Cell RANKL Expression In Multiple Myeloma-Bone Disease At Diagnosis and In The Setting Of Frontline Treatment" @default.
• W2472541503 doi "https://doi.org/10.1182/blood.v122.21.5353.5353" @default.
• W2472541503 hasPublicationYear "2013" @default.
• W2472541503 type Work @default.
• W2472541503 sameAs 2472541503 @default.
• W2472541503 citedByCount "0" @default.
• W2472541503 crossrefType "journal-article" @default.
• W2472541503 hasAuthorship W2472541503A5000873286 @default.
• W2472541503 hasAuthorship W2472541503A5003063004 @default.
• W2472541503 hasAuthorship W2472541503A5004697477 @default.
• W2472541503 hasAuthorship W2472541503A5005276198 @default.
• W2472541503 hasAuthorship W2472541503A5009981948 @default.
• W2472541503 hasAuthorship W2472541503A5016695149 @default.
• W2472541503 hasAuthorship W2472541503A5033896229 @default.
• W2472541503 hasAuthorship W2472541503A5046114745 @default.
• W2472541503 hasAuthorship W2472541503A5057593886 @default.
• W2472541503 hasAuthorship W2472541503A5064478569 @default.
• W2472541503 hasAuthorship W2472541503A5072483254 @default.
• W2472541503 hasAuthorship W2472541503A5083991779 @default.
• W2472541503 hasConcept C126322002 @default.
• W2472541503 hasConcept C143998085 @default.
• W2472541503 hasConcept C170033053 @default.
• W2472541503 hasConcept C170493617 @default.
• W2472541503 hasConcept C2776033226 @default.
• W2472541503 hasConcept C2776139714 @default.
• W2472541503 hasConcept C2776169692 @default.
• W2472541503 hasConcept C2776286101 @default.
• W2472541503 hasConcept C2776364478 @default.
• W2472541503 hasConcept C2776541429 @default.
• W2472541503 hasConcept C2776886416 @default.
• W2472541503 hasConcept C2777083390 @default.
• W2472541503 hasConcept C2777478702 @default.
• W2472541503 hasConcept C2779428903 @default.
• W2472541503 hasConcept C2780007613 @default.
• W2472541503 hasConcept C71924100 @default.
• W2472541503 hasConcept C88045685 @default.
• W2472541503 hasConceptScore W2472541503C126322002 @default.
• W2472541503 hasConceptScore W2472541503C143998085 @default.
• W2472541503 hasConceptScore W2472541503C170033053 @default.
• W2472541503 hasConceptScore W2472541503C170493617 @default.
• W2472541503 hasConceptScore W2472541503C2776033226 @default.
• W2472541503 hasConceptScore W2472541503C2776139714 @default.
• W2472541503 hasConceptScore W2472541503C2776169692 @default.
• W2472541503 hasConceptScore W2472541503C2776286101 @default.
• W2472541503 hasConceptScore W2472541503C2776364478 @default.
• W2472541503 hasConceptScore W2472541503C2776541429 @default.
• W2472541503 hasConceptScore W2472541503C2776886416 @default.
• W2472541503 hasConceptScore W2472541503C2777083390 @default.
• W2472541503 hasConceptScore W2472541503C2777478702 @default.
• W2472541503 hasConceptScore W2472541503C2779428903 @default.
• W2472541503 hasConceptScore W2472541503C2780007613 @default.
• W2472541503 hasConceptScore W2472541503C71924100 @default.
• W2472541503 hasConceptScore W2472541503C88045685 @default.
• W2472541503 hasLocation W24725415031 @default.
• W2472541503 hasOpenAccess W2472541503 @default.
• W2472541503 hasPrimaryLocation W24725415031 @default.
• W2472541503 hasRelatedWork W1558015393 @default.
• W2472541503 hasRelatedWork W2031627997 @default.
• W2472541503 hasRelatedWork W2092048147 @default.
• W2472541503 hasRelatedWork W2172079007 @default.
• W2472541503 hasRelatedWork W2253902778 @default.
• W2472541503 hasRelatedWork W2316199813 @default.
• W2472541503 hasRelatedWork W2347814392 @default.
• W2472541503 hasRelatedWork W2364312993 @default.
• W2472541503 hasRelatedWork W2369801658 @default.
• W2472541503 hasRelatedWork W2398401001 @default.
• W2472541503 hasRelatedWork W2414196177 @default.
• W2472541503 hasRelatedWork W2415377036 @default.
• W2472541503 hasRelatedWork W2424612714 @default.
• W2472541503 hasRelatedWork W2427556589 @default.
• W2472541503 hasRelatedWork W2462610380 @default.
• W2472541503 hasRelatedWork W2566645010 @default.
• W2472541503 hasRelatedWork W2593669484 @default.
• W2472541503 hasRelatedWork W2991828753 @default.
• W2472541503 hasRelatedWork W3004083177 @default.
• W2472541503 hasRelatedWork W3028842219 @default.
• W2472541503 isParatext "false" @default.
• W2472541503 isRetracted "false" @default.
• W2472541503 magId "2472541503" @default.
• W2472541503 workType "article" @default.